India to United Kingdom: Emtricitabine Export Trade Route
India has recorded 36 verified shipments of Emtricitabine exported to United Kingdom, representing a combined trade value of $7.7M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $214.3K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 51% of total export value with 8 shipments worth $3.9M USD. On the buying side, GLENMARK PHARMACEUTICALS EUROPE LTD is the largest importer in United Kingdom with $3.6M USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, HETERO LABS LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Emtricitabine corridor is one of India's established pharmaceutical export routes, with 36 shipments documented worth a combined $7.7M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's emtricitabine manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $214.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with emtricitabine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 21.0%, placing it at rank #8 among India's top emtricitabine export destinations globally.
On the import side, key buyers of Indian emtricitabine in United Kingdom include GLENMARK PHARMACEUTICALS EUROPE LTD, LUPIN HEALTHCARE (UK) LIMITED, LUPIN HEALTHCARE UK LIMITED and 9 others. GLENMARK PHARMACEUTICALS EUROPE LTD is the single largest importer with 4 shipments valued at $3.6M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#8
- Annual growth+21.0%
- Demand growth+17.9%
- Regulatory ease86/100
Top 10 Indian Emtricitabine Exporters to United Kingdom
Showing top 10 of 6 Indian suppliers exporting Emtricitabine to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD Avg $489.3K per shipment | 8 | $3.9M | 50.7% |
| 2 | LUPIN LIMITED Avg $221.1K per shipment | 13 | $2.9M | 37.3% |
| 3 | HETERO LABS LIMITED Avg $132.8K per shipment | 5 | $663.9K | 8.6% |
| 4 | MACLEODS PHARMACEUTICALS LIMITED Avg $32.4K per shipment | 8 | $259.4K | 3.4% |
| 5 | 3S CORPORATION Avg $1.7K per shipment | 1 | $1.7K | 0.0% |
| 6 | N CHIMANLAL ENTERPRISES Avg $95 per shipment | 1 | $95 | 0.0% |
This table shows the top 10 of 6 Indian companies exporting emtricitabine to United Kingdom, ranked by total trade value. The listed exporters are: MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, HETERO LABS LIMITED, MACLEODS PHARMACEUTICALS LIMITED, 3S CORPORATION, N CHIMANLAL ENTERPRISES. MACLEODS PHARMACEUTICALS LTD is the dominant supplier with 8 shipments worth $3.9M USD, giving it a 51% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Emtricitabine Importers in United Kingdom
Showing top 10 of 12 known buyers in United Kingdom receiving Emtricitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian emtricitabine in United Kingdom include GLENMARK PHARMACEUTICALS EUROPE LTD, LUPIN HEALTHCARE (UK) LIMITED, LUPIN HEALTHCARE UK LIMITED, NA, GLENMARK PHARMACEUTICALS S R O CITY TOWER HVEZDOVA, among 12 total buyers. The largest importer is GLENMARK PHARMACEUTICALS EUROPE LTD, accounting for $3.6M USD across 4 shipments — representing 47% of all emtricitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLENMARK PHARMACEUTICALS EUROPE LTD | 4 | $3.6M | 46.8% |
| 2 | LUPIN HEALTHCARE (UK) LIMITED | 11 | $2.2M | 28.5% |
| 3 | LUPIN HEALTHCARE UK LIMITED | 2 | $675.6K | 8.8% |
| 4 | NA | 3 | $320.6K | 4.2% |
| 5 | GLENMARK PHARMACEUTICALS S R O CITY TOWER HVEZDOVA | 3 | $238.1K | 3.1% |
| 6 | TO THE ORDER OF | 1 | $227.1K | 2.9% |
| 7 | GLENMARK PHARMACEUTICALS EUROPRIVATE LIMITED | 2 | $150.7K | 2.0% |
| 8 | M S TO THE ORDER OF ALLOGA UK | 1 | $116.1K | 1.5% |
| 9 | GLENMARK PHARMACEUTICALS EUROPE LIMITED | 6 | $108.7K | 1.4% |
| 10 | GLENMARK PHARMACEUTICALS EUROPE LT | 1 | $69.8K | 0.9% |
Showing top 10 of 12 Emtricitabine importers in United Kingdom on this route.
Top 10 Emtricitabine Formulations Imported by United Kingdom
Showing top 10 of 22 product formulations shipped on the India to United Kingdom Emtricitabine route, ranked by trade value
United Kingdom imports a wide range of emtricitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FILM COATED TABLETS (600 — accounts for $3.5M USD across 2 shipments. There are 22 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FILM COATED TABLETS (600 | 2 | $3.5M | 45.1% |
| 2 | EMTRICITABINE 200MG+TENO PHO.245MG TABLETS UK(EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG)-1BTLx30TABS | 4 | $571.4K | 7.4% |
| 3 | EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL | 2 | $452.3K | 5.9% |
| 4 | PHARMA : EMTRICITABINE 200MG + TENOFOVIR DISOPROXIL (AS PHOSPHATE) 245MG TABLETS UK - 1 BTL x 30TABS | 1 | $371.2K | 4.8% |
| 5 | EMTRICITABINE 200MG+TENOFOVIR DISOPROXILAS PHOSPHATE 245MG TABLETS-1BTLx30TABSOTHER-MEDICINE PUT UP FOR RETAIL SALE | 1 | $359.0K | 4.7% |
| 6 | PHARMA :EMTRICITABINE 200MG + TENOFOVIRDISOPROXIL 245MG TABLETS (AS PHOSPHATE)UK - 1 BTL X 30 TABS | 1 | $357.1K | 4.6% |
| 7 | EMTR TENO DIS PH 200MG 245MG TABLETS UK EMTRICITABINE 200MG TENOFOVIR DISOPROXIL AS PHOSPHATE 245MG 1BTLx30 TABS | 1 | $316.6K | 4.1% |
| 8 | EMTRICITABINE 200MG+TENO PHO.245MG TABLETS UK (EMTRICITABINE 200MG+TENOFOVIR DISOPROXIL(AS PHOSPHATE) 245MG)-1BTLx30TABS | 1 | $300.8K | 3.9% |
| 9 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FILM COATED TABLETS 600 | 3 | $238.1K | 3.1% |
| 10 | TENOFOVIR DISOPROXIL FUMARATE 245 EMTRICITABINE 200 TABS 31725x30 s PACK | 1 | $227.1K | 2.9% |
Showing top 10 of 22 Emtricitabine formulations imported by United Kingdom on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 18 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's emtricitabine exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, HETERO LABS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $214.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as emtricitabine 200mg+teno pho.245mg tablets uk(emtricitabine 200mg+tenofovir disoproxil (as phosphate) 245mg)-1btlx30tabs and emtricitabine 200mg+tenofovir disoproxil, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, GLENMARK PHARMACEUTICALS EUROPE LTD is the largest importer with 4 shipments worth $3.6M USD — representing 47% of all emtricitabine imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $7.7M
- Avg. Shipment
- $214.3K
- Suppliers
- 6
- Buyers
- 12
- Transit (Sea)
- ~34 days
- Annual Growth
- +21.0%
Related Analysis
Reverse Direction
United Kingdom → India — Emtricitabine (Import)Other Emtricitabine Routes
Unlock the Full India to United Kingdom Emtricitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 36 shipments on this route.
Frequently Asked Questions — India to United Kingdom Emtricitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Emtricitabine to United Kingdom?
The leading Indian exporters of Emtricitabine to United Kingdom are MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, HETERO LABS LIMITED. MACLEODS PHARMACEUTICALS LTD holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Emtricitabine exports from India to United Kingdom?
India exports Emtricitabine to United Kingdom worth approximately $7.7M USD across 36 recorded shipments. The average value per shipment is $214.3K USD.
Q Which ports does India use to ship Emtricitabine to United Kingdom?
The most active port of origin is SAHAR AIR with 18 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United Kingdom for Emtricitabine?
The average transit time for Emtricitabine shipments from India to United Kingdom is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United Kingdom Emtricitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.0% with demand growth tracking at 17.9%. The route is ranked #8 among India's top Emtricitabine export destinations globally.
Q How many suppliers are active on the India to United Kingdom Emtricitabine route?
There are currently 6 active Indian suppliers exporting Emtricitabine to United Kingdom. The market is moderately concentrated with MACLEODS PHARMACEUTICALS LTD accounting for 51% of total shipment value.
Q Who are the main importers of Emtricitabine from India in United Kingdom?
The leading importers of Indian Emtricitabine in United Kingdom include GLENMARK PHARMACEUTICALS EUROPE LTD, LUPIN HEALTHCARE (UK) LIMITED, LUPIN HEALTHCARE UK LIMITED, NA, GLENMARK PHARMACEUTICALS S R O CITY TOWER HVEZDOVA. GLENMARK PHARMACEUTICALS EUROPE LTD is the largest buyer with 4 shipments worth $3.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Emtricitabine.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 12 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 36 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
36 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists